No insider purchase over the last 90 days. The latest, by 张国刚, was filed 06 Jun 2024.
Baolingbao Biology Co.,Ltd.: what insiders have been doing
Baolingbao Biology Co.,Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Baolingbao Biology Co.,Ltd. The previous disclosure was published on 6 June 2024.
Looking back to 2024, when coverage begins, insiders filed 2 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Since the insiders bought
- +104.8%Entry CN¥5.80 · Close at T+365 CN¥11.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Baolingbao Biology Co.,Ltd.
保龄宝 is a company focused on the health and pharmaceutical sector, providing health-related products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
